logo
UW researchers create new low-carbon concrete with seaweed

UW researchers create new low-carbon concrete with seaweed

Yahoo18-07-2025
The Brief
University of Washington researchers have created a type of concrete that is more eco-friendly.
The concrete is infused with seaweed, which acts as a substance that absorbs and reduces the release of carbon dioxide.
SEATTLE - University of Washington researchers have created a new type of concrete that could cut concrete's carbon footprint.
Concrete is the second most used material by humans annually, behind water, but researchers have created seaweed-infused cement – a major component of concrete – that may emit less carbon dioxide than regular concrete.
What we know
Cement is the source of nearly 10% of all CO2 emissions worldwide, but students at UW have been addressing this problem by creating a low-carbon concrete powder infused with seaweed.
One kilogram of cement will emit almost a kilogram of CO2 in return from fossil fuels used to heat the materials and calcination, a chemical reaction during the heating of raw materials like cement.
Seaweed can combat the emissions as a carbon sink – something that absorbs more carbon than it releases – and, when mixed with concrete and made into cement, has a 21% lower global warming potential while keeping the strength of regular cement, according to the UW study.
Researchers built and used a machine-learning model to shorten the time it would take to find an ideal formula for seaweed-infused concrete. What may have taken research teams months in the past to complete, took the UW team 28 days.
Moving forward, researchers will continue to study and test how the infusion of seaweed may affect cement strength and structure, and will use machine learning to expedite the process again.
The project and research paper were co-authored by Meng-Yen Lin, a UW materials science and engineering doctoral student, Paul Grandgeorge, a former UW materials science and engineering postdoctoral researcher, and Kristen Severson, a principal researcher at Microsoft Research. The project was funded by Microsoft Research.
Learn more about the research project here.
The Source
Information in this article is from a University of Washington news release.
MORE NEWS FROM FOX 13 SEATTLE
Police dashcam video shows triple-murder suspect Travis Decker days before crime
Judge lifts gag order in Idaho murders case against Bryan Kohberger
Idaho hiker mistaken for Travis Decker tells all
Police, prosecutors disagree on charges for Renton transit shooting suspects
Grandmother shot near Pioneer Square 'thought it was a rock' that hit her
Buyer secures iconic Seattle 'Spite House' under listing price
Seattle Kraken release schedule for 2025-26 season
To get the best local news, weather and sports in Seattle for free, sign up for the daily FOX Seattle Newsletter.
Download the free FOX LOCAL app for mobile in the Apple App Store or Google Play Store for live Seattle news, top stories, weather updates and more local and national news.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'Fantastic Four' wins battle of heroes at N. America box office
'Fantastic Four' wins battle of heroes at N. America box office

Yahoo

time22 minutes ago

  • Yahoo

'Fantastic Four' wins battle of heroes at N. America box office

"The Fantastic Four: First Steps," Disney's hotly anticipated reboot of the Marvel Comics superhero franchise, conquered the North American weekend box office, earning $118 million and sidelining "Superman," industry estimates showed Sunday. "Fantastic Four" -- starring actor-of-the-moment Pedro Pascal, Vanessa Kirby, Emmy winner Ebon Moss-Bachrach and Joseph Quinn ("Stranger Things') -- tells the story of a team of heroes trying to save a retro-futuristic world from the evil Galactus. "This is an outstanding opening," said David A. Gross of Franchise Entertainment Research. "'Fantastic Four' was a modest and struggling superhero series; it just caught up with the biggest and the best." "Superman," the latest big-budget action film featuring the iconic superhero from Warner Bros. and DC Studios, slipped to second place at $24.9 million, Exhibitor Relations said. That puts the global take of the film, starring David Corenswet as the Man of Steel, over the $500 million mark. "Jurassic World: Rebirth" -- the latest installment in the blockbuster dinosaur saga -- finished in third place at $13 million. Its worldwide total stands at $672.5 million. The Universal film, starring Scarlett Johansson, Jonathan Bailey and Mahershala Ali, takes viewers to an abandoned island research facility, where secrets -- and genetically mutated dinosaurs -- are lurking. "F1: The Movie," the Apple and Warner Bros. flick starring Brad Pitt as a washed-up Formula One driver who gets one last shot at redemption, moved up to fourth place at $6.2 million. "Smurfs," the latest film featuring the adorable blue creatures and starring Rihanna as Smurfette, slipped to fifth place in only its second week in theaters with $5.4 million in North American ticket sales. "The box office is on an excellent run that started two weeks ago," Gross said. "These are not the good old days, but 'Fantastic Four' and 'Superman' are performing extremely well. Superheroes are showing some swagger, and it's good news for the industry." Rounding out the top 10 were: "I Know What You Did Last Summer" ($5.1 million) "How to Train Your Dragon" ($2.8 million) "Eddington" ($1.7 million) "Saiyaara" ($1.3 million) "Oh, Hi!" ($1.1 million) bur-sst/ksb Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Human Babies Aren't Supposed to Have 3 Parents—but Now They Can
Human Babies Aren't Supposed to Have 3 Parents—but Now They Can

Yahoo

timean hour ago

  • Yahoo

Human Babies Aren't Supposed to Have 3 Parents—but Now They Can

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Here's what you'll learn when you read this story: The first babies with three biological parents were born out of a new technique to prevent mitochondrial disease. The nucleus of an egg fertilized in vitro was transferred into a donor egg without a nucleus, but with viable mitochondria. Eight healthy babies, including a set of twins, were born with low to undetectable levels of mitochondrial mutations. The only creatures known to conceive offspring from more than two parents are salamanders. Females from the genus Ambystoma (which are notoriously promiscuous) mate with up to three different males, and that DNA is then incorporated into what is known as a triploid genome in their offspring. Now a version of this has become possible in humans. It seems limb regeneration isn't the only way medical intervention can put humans on salamanders' level. Being born with three genomes is not a phenomenon that occurs naturally in Homo sapiens, but in an attempt to prevent certain genetic conditions caused by mutations in the mitochondria, scientists have found a way. Mitochondrial DNA or mtDNA is exclusively passed down from the maternal side. Dysfunction in the mitochondria can lead to metabolic diseases characterized by symptoms such as seizures, developmental delays, blindness, and loss of muscular function. Some can even be fatal. Mitochondrial diseases occur in about 1 in every 5,000 people. They were previously only preventable by using a donor egg or foregoing the conception of biological children altogether. This is why pediatric neurologist Bobby McFarland, of Newcastle University in the UK, led an experimental study that would reduce and potentially eliminate the risk of mitochondrial disease with a new method of in vitro fertilization. McFarland and his research team wanted see if removing the nucleus of an egg and placing it in a donor egg with viable mitochondria would result in healthy offspring. 'We found that pronuclear transfer, a form of mitochondrial donation, was effective in reducing the level of pathogenic mtDNA variant to substantially below the threshold for clinical disease in the offspring of women with homoplasmic (or high heteroplasmic) levels,' he said in a study recently published in the New England Journal of Medicine. When mitochondria are homoplasmic, all copies produced by cell division have mutations. Mutation levels vary in heteroplasmic mitochondria. Preimplantation genetic testing (PGT) can screen for these abonormalities, and women with homoplasmy or high levels of heteroplasmy can benefit from what is now known as pronuclear transfer. This involves eggs from both the mother and donor being fertilized with the father's sperm in vitro. Nuclei are then removed from both eggs after ten hours. Since the nucleus carries most genetic material and has no connection to mitochondrial disease, the mother's nucleus is implanted into the donor egg to take advantage of its mitochondria. While there is a chance that a few of the mother's mitochondria may end up in the embryo, it is unlikely to cause a debilitating disease. Levels of defective mitochondria in offspring conceived via pronuclear transfer were low enough to escape that fate. Eight pregnancies (including a set of twins) resulted from the experiment, and while there were a few minor health problems in the newborns, these were either treatable or corrected themselves. Not only were levels of heteroplasty low for the babies, but undetectable in five of them. Developmental progress also turned out to be normal. Though one baby had a form of infant epilepsy, and another had heart arrhythmia and hyperlipidemia, or high levels of fats and lipids in the blood, both of these conditions were treated and resolved. Whether the hyperlipidemia was even caused by mtDNA is uncertain, especially because the mother also had severe hyperlipidemia during her pregnancy. Though there was a chance that any of the mothers with pathogenic mtDNA had a higher risk of complications during pregnancy, which could possibly cause their children to have health issues, there is no proof for now. 'We are assessing, over the long term, the health and extent of heteroplasmy (if detectable) of the offspring,' McFarland and his team said. 'Indeed, the role of mitochondrial donation as a choice for women with a heritable pathogenic mtDNA variant will only be established with the availability of additional data.' You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50 Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store